Literature DB >> 16435196

Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulphatase B gene in South American patients.

M F G Petry1, K Nonemacher, J C Sebben, I V D Schwartz, A C M Azevedo, M G Burin, A R de Rezende, C A Kim, R Giugliani, S Leistner-Segal.   

Abstract

Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome, MPS VI) is an autosomal recessive disorder caused by deficiency of N-acetylgalactosamine-4-sulphatase (ARSB),which leads to the lysosomal accumulation and excretion of dermatan sulphate (DS). In this study, 13 unrelated MPS VI patients (12 Brazilian and 1 Chilean) were investigated regarding the identification of the ARSB gene mutations using PCR, SSCP and sequencing. The exons with altered mobility on SSCP were sequenced, as well as all the exons of patients with no SSCP alteration. Seven novel mutations were identified: D59N, L72R, Q88H, P93S, R197X, 1279delA and c.1143-8T > G. The previously reported mutations 1533del23, R315Q and 427delG were found in six, three and two alleles respectively. The other mutations already reported, S384N and G144R, were found in only one allele. In addition, three polymorphisms previously described (V358M, V376M and P397P) were detected in the patients analysed. Our findings are in agreement with the literature confirming the great genetic heterogeneity associated with MPS VI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16435196     DOI: 10.1007/s10545-005-0020-2

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  13 in total

Review 1.  Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase.

Authors:  T Litjens; J J Hopwood
Journal:  Hum Mutat       Date:  2001-10       Impact factor: 4.878

2.  Structure of the human arylsulfatase B gene.

Authors:  S Modaressi; K Rupp; K von Figura; C Peters
Journal:  Biol Chem Hoppe Seyler       Date:  1993-05

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Deficiency of chondroitin sulfate N-acetylgalactosamine 4-sulfate sulfatase in Maroteaux-Lamy syndrome.

Authors:  R Matalon; B Arbogast; A Dorfman
Journal:  Biochem Biophys Res Commun       Date:  1974-12-23       Impact factor: 3.575

5.  [Identification of mutations in the arylsulfatase B gene in Russian mucopolysaccharidosis type VI patients].

Authors:  E Iu Voskoboeva; K D Krasnopol'skaia; K Peters; K von Figura
Journal:  Genetika       Date:  2000-06

6.  Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy.

Authors:  L Karageorgos; P Harmatz; J Simon; A Pollard; P R Clements; D A Brooks; John J Hopwood
Journal:  Hum Mutat       Date:  2004-03       Impact factor: 4.878

7.  Identification of a novel mutation in the ARSB gene that is frequent among Brazilian MPSVI patients.

Authors:  Márcia Fernanda Gomes Petry; Tatiana Dieter; Maira Burin; Roberto Giugliani; Sandra Leistner
Journal:  Genet Test       Date:  2003

8.  Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B.

Authors:  C Peters; B Schmidt; W Rommerskirch; K Rupp; M Zühlsdorf; M Vingron; H E Meyer; R Pohlmann; K von Figura
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

9.  Human arylsulfatase B: MOPAC cloning, nucleotide sequence of a full-length cDNA, and regions of amino acid identity with arylsulfatases A and C.

Authors:  E H Schuchman; C E Jackson; R J Desnick
Journal:  Genomics       Date:  1990-01       Impact factor: 5.736

10.  Maroteaux-lamy syndrome: five novel mutations and their structural localization.

Authors:  G R Villani; N Balzano; D Vitale; M Saviano; V Pavone; P Di Natale
Journal:  Biochim Biophys Acta       Date:  1999-02-24
View more
  14 in total

1.  Identification of a novel arylsulfatase B gene mutation in three unrelated Iranian mucopolysaccharidosis type-VI patients with different phenotype severity.

Authors:  Nayerossadat Nouri; Nargesossadat Nouri; Omid Aryani; Behnam Kamalidehghan; Massoud Houshmand
Journal:  Iran Biomed J       Date:  2012

2.  Epidemiology of mucopolysaccharidoses.

Authors:  Shaukat A Khan; Hira Peracha; Diana Ballhausen; Alfred Wiesbauer; Marianne Rohrbach; Matthias Gautschi; Robert W Mason; Roberto Giugliani; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2017-05-26       Impact factor: 4.797

3.  Identification of eleven different mutations including six novel, in the arylsulfatase B gene in Iranian patients with mucopolysaccharidosis type VI.

Authors:  Rokhsareh Jafaryazdi; Sedigheh Shams; Anna Isaian; Aria Setoodeh; Shahram Teimourian
Journal:  Mol Biol Rep       Date:  2019-04-13       Impact factor: 2.316

Review 4.  Mucopolysaccharidosis VI.

Authors:  Vassili Valayannopoulos; Helen Nicely; Paul Harmatz; Sean Turbeville
Journal:  Orphanet J Rare Dis       Date:  2010-04-12       Impact factor: 4.123

5.  Molecular Analysis of Turkish Maroteaux-Lamy Patients and Identification of One Novel Mutation in the Arylsulfatase B (ARSB) Gene.

Authors:  Alessandra Zanetti; Neslihan Onenli-Mungan; Nursel Elcioglu; Mehmet Nuri Ozbek; Deniz Kör; Elisabetta Lenzini; Maurizio Scarpa; Rosella Tomanin
Journal:  JIMD Rep       Date:  2013-11-16

6.  Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment.

Authors:  Roberto Giugliani; Andressa Federhen; Maria Verônica Muñoz Rojas; Taiane Vieira; Osvaldo Artigalás; Louise Lapagesse Pinto; Ana Cecília Azevedo; Angelina Acosta; Carmen Bonfim; Charles Marques Lourenço; Chong Ae Kim; Dafne Horovitz; Denize Bonfim; Denise Norato; Diane Marinho; Durval Palhares; Emerson Santana Santos; Erlane Ribeiro; Eugênia Valadares; Fábio Guarany; Gisele Rosone de Lucca; Helena Pimentel; Isabel Neves de Souza; Jordão Correa; José Carlos Fraga; José Eduardo Goes; José Maria Cabral; José Simionato; Juan Llerena; Laura Jardim; Liane Giuliani; Luiz Carlos Santana da Silva; Mara L Santos; Maria Angela Moreira; Marcelo Kerstenetzky; Márcia Ribeiro; Nicole Ruas; Patricia Barrios; Paulo Aranda; Rachel Honjo; Raquel Boy; Ronaldo Costa; Carolina Souza; Flavio F Alcantara; Silvio Gilberto A Avilla; Simone Fagondes; Ana Maria Martins
Journal:  Genet Mol Biol       Date:  2010-12-01       Impact factor: 1.771

7.  Mucopolysaccharidoses in northern Brazil: Targeted mutation screening and urinary glycosaminoglycan excretion in patients undergoing enzyme replacement therapy.

Authors:  Gustavo M Viana; Nathália O de Lima; Rosely Cavaleiro; Erik Alves; Isabel C N Souza; Raimunda Feio; Sandra Leistner-Segal; Ida Schwartz; Roberto Giugliani; Luiz C Santana da Silva
Journal:  Genet Mol Biol       Date:  2011-07-01       Impact factor: 1.771

Review 8.  Diagnostic and treatment strategies in mucopolysaccharidosis VI.

Authors:  Filippo Vairo; Andressa Federhen; Guilherme Baldo; Mariluce Riegel; Maira Burin; Sandra Leistner-Segal; Roberto Giugliani
Journal:  Appl Clin Genet       Date:  2015-10-30

Review 9.  Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literature.

Authors:  Agnieszka Jurecka; Ekaterina Zakharova; Vera Malinova; Elena Voskoboeva; Anna Tylki-Szymańska
Journal:  Clin Rheumatol       Date:  2013-11-13       Impact factor: 2.980

10.  Mutations in ARSB in MPS VI patients in India.

Authors:  Juby Mathew; Sujatha M Jagadeesh; Meenakshi Bhat; S Udhaya Kumar; Saravanamuthu Thiyagarajan; Sudha Srinivasan
Journal:  Mol Genet Metab Rep       Date:  2015-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.